Int J Dermatol 58(10):12021204
According to the UK Summary of Product Characteristics (SmPC), the most frequently reported adverse effects are gastrointestinal in nature, reflecting the drug's mechanism of slowing gastric emptying and affecting the digestive system
Reconstitution: 1.0 mL per 10 mg vial (10 mg/mL) for convenient singlesyringe administration
A 2021 study published in the New England Journal of Medicine (Wilding et al., NEJM, 2021) found that semaglutide 2.4 mg produced an average weight loss of approximately 14.9% of body weight over 68 weeks in adults with obesity, compared to 2.4% in the placebo group
[1] [7] As such, it remains an experimental treatment and is not available through standard NHS prescribing pathways
On this, there is no agreement between the two except to say that my B5 levels seem mediocre and perhaps I have a bigger problem utilizing the B5